What is the price target for 1FME stock?
27 analysts have analysed 1FME.MI and the average price target is 45.83 EUR. This implies a price increase of 14.49% is expected in the next year compared to the current price of 40.03.
FRESENIUS MEDICAL CARE AG (1FME.MI) Forecast, Price Target & Analyst Ratings
BIT:1FME • DE0005785802
Current stock price
40.03 EUR
-0.51 (-1.26%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FRESENIUS MEDICAL CARE AG (1FME.MI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- €0.79
- Revenue Estimate
- 4.854B
Price Target Details & History
Consensus Price Target and Range
Mean target
€45.83
Upside
+ 14.49%
From current price of €40.03 to mean target of €45.83, Based on 27 analyst forecasts
Low
€22.43
Median
€47.99
High
€65.16
Price Target Revisions
1 Month
-4.20%
3 Months
-7.71%
Price Target Summary
27 Wall Street analysts provided a forecast for the next 12 months for 1FME.MI. The average price target is 45.83 EUR. This implies a price increase of 14.49% is expected in the next year compared to the current price of 40.03.
The average price target has been revised downward by 7.71% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
65.93%
1FME.MI was analyzed by 27 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about 1FME.MI.
In the last month the buy percentage rose by 8 points. So the trust of analysts is improving.
1FME.MI was analyzed by 27 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- €0.79
- Revenue Estimate
- 4.854B
- Revenue Q2Q
- -0.55%
- EPS Q2Q
- -6.00%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
-3.38%
Revenue (3 Months)
N/A
EPS (1 Month)
6.36%
EPS (3 Months)
N/A
Next Earnings Summary
1FME.MI is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.79 EUR and the consensus revenue estimate is 4.85B EUR.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.454B 0.29% | 19.336B -0.61% | 19.628B 1.51% | 20.176B 2.79% | 21.009B 4.13% | 22.679B 7.95% | 22.704B 0.11% | 23.785B 4.76% | 24.256B 1.98% | 25.192B 3.86% | 26.145B 3.78% | |
| EBITDA YoY % growth | 3.03B -3.03% | 3.008B -0.73% | 3.266B 8.57% | 3.683B 12.77% | 3.905B 6.03% | 4.1B 4.99% | 4.187B 2.12% | 4.68B 11.77% | 4.871B 4.08% | 5.046B 3.59% | 5.225B 3.55% | |
| EBIT YoY % growth | 1.278B -0.65% | 1.266B -0.97% | 1.766B 39.46% | 2.16B 22.34% | 2.389B 10.60% | 2.822B 18.12% | 2.988B 5.88% | 3.286B 9.97% | 3.472B 5.66% | 3.609B 3.95% | 3.75B 3.91% | |
| Operating Margin | 6.57% | 6.55% | 9.00% | 10.71% | 11.37% | 12.44% | 13.16% | 13.82% | 14.31% | 14.33% | 14.34% | |
| EPS YoY % growth | 2.57 -17.23% | 3.25 26.66% | 3.55 9.36% | 4.15 16.67% | 4.71 13.57% | 5.59 18.65% | 5.78 3.42% | 6.38 10.32% | 6.64 4.09% | 7.13 7.49% | 7.57 6.15% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.79 -6.00% | 0.79 -13.43% | 0.88 -19.66% | 0.76 7.56% |
| Revenue Q2Q % growth | 4.854B -0.55% | 4.988B 4.09% | 5.124B 4.89% | 5.299B 5.81% |
| EBITDA Q2Q % growth | 851.66M 13.30% | 932.15M -19.33% | 984.25M -37.62% | 1.042B -49.71% |
| EBIT Q2Q % growth | 474.46M 32.79% | 517.54M 34.11% | 568.13M 26.00% | 668.62M 17.01% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
16.28%
EPS Next 5 Year
12.40%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.72%
Revenue Next 5 Year
3.79%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
25.14%
EBIT Next 5 Year
17.47%
FRESENIUS MEDICAL CARE AG / 1FME.MI Forecast FAQ
Can you provide the upcoming earnings date for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (1FME.MI) will report earnings on 2026-05-05.
Can you provide the consensus estimates for FRESENIUS MEDICAL CARE AG next earnings?
The consensus EPS estimate for the next earnings of FRESENIUS MEDICAL CARE AG (1FME.MI) is 0.79 EUR and the consensus revenue estimate is 4.85B EUR.
What is the expected long term growth rate for FRESENIUS MEDICAL CARE AG (1FME.MI)?
The expected long term growth rate for FRESENIUS MEDICAL CARE AG (1FME.MI) is 4.72%.